These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34080517)

  • 21. Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis.
    Moore JE; Garcia A; Sanyal S; Saunders S; Portnoy JE; Hu A; Sataloff RT
    J Voice; 2013 Nov; 27(6):765-8. PubMed ID: 24128893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic bevacizumab for recurrent respiratory papillomatosis.
    Baday YI; Ongkasuwan J; Venkatramani R
    Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110352. PubMed ID: 32906078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Papillomavirus Vaccination as an Adjuvant Therapy for Recurrent Respiratory Papillomatosis: Additional Case Series.
    Matsuzaki H; Makiyama K; Hasegawa H; Asai R; Morita M; Oshima T
    J Voice; 2024 Jan; 38(1):204-209. PubMed ID: 34600799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery and Adjuvant Therapy Improve Derkay Scores in Adult and Pediatric Respiratory Papillomatosis.
    Hock K; Kennedy A; Howell R; Friedman A; de Alarcon A; Khosla S
    Laryngoscope; 2022 Dec; 132(12):2420-2426. PubMed ID: 35119691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis.
    Avelino MA; Zaiden TC; Gomes RO
    Braz J Otorhinolaryngol; 2013; 79(5):636-42. PubMed ID: 24141682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
    Donne AJ; Rothera MP; Homer JJ
    Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):939-44. PubMed ID: 18502519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Use of the Human Papillomavirus Vaccine on Recurrent Respiratory Papillomatosis: A Systematic Review and Meta-Analysis.
    Rosenberg T; Philipsen BB; Mehlum CS; Dyrvig AK; Wehberg S; Chirilǎ M; Godballe C
    J Infect Dis; 2019 Mar; 219(7):1016-1025. PubMed ID: 30358875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intralesional cidofovir as adjuvant for the successful management of aggressive respiratory papillomatosis in an infant.
    Durvasula VS; Richter GT
    Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1912-5. PubMed ID: 24063771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic use of the HPV vaccine in Recurrent Respiratory Papillomatosis: A case report.
    Sullivan C; Curtis S; Mouzakes J
    Int J Pediatr Otorhinolaryngol; 2017 Feb; 93():103-106. PubMed ID: 28109479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in recurrent respiratory papillomatosis treatment.
    Ballestas SA; Shelly S; Soriano RM; Klein A
    Acta Otorrinolaringol Esp (Engl Ed); 2021; 72(2):109-120. PubMed ID: 32312478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Squamous Cell Papillomatosis in the Setting of Recurrent Respiratory Papillomatosis.
    Bentley PL; Coulter MJ; Nelson BL
    Head Neck Pathol; 2019 Jun; 13(2):235-238. PubMed ID: 29594918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current use of intralesional cidofovir for recurrent respiratory papillomatosis.
    Derkay CS; Volsky PG; Rosen CA; Pransky SM; McMurray JS; Chadha NK; Froehlich P
    Laryngoscope; 2013 Mar; 123(3):705-12. PubMed ID: 23070868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion.
    Rivière F; Gille T; Le Tinier JY; Gharbi N; Khalil A; Wislez M; Cadranel J
    Scand J Infect Dis; 2011 Feb; 43(2):112-4. PubMed ID: 21039305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Follow-Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis.
    Evers G; Schliemann C; Beule A; Schmidt LH; Schulze AB; Kessler C; Hoffmann TK; Wiewrodt R; Groll AH; Bleckmann A; Rudack C; Berdel WE; Mohr M
    Laryngoscope; 2021 Jun; 131(6):E1926-E1933. PubMed ID: 33382105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infantile recurrent respiratory papillomatosis: review of adjuvant therapies.
    Patel A; Orban N
    J Laryngol Otol; 2021 Nov; 135(11):958-963. PubMed ID: 34470689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience.
    So RJ; Rayle C; Joo HH; Huang EY; Seiwert TY; Raabe EH; Best SR
    Laryngoscope; 2024 Jul; 134(7):3253-3259. PubMed ID: 38525973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis.
    Ivancic R; Iqbal H; deSilva B; Pan Q; Matrka L
    Clin Exp Immunol; 2020 Feb; 199(2):131-142. PubMed ID: 31628850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPV vaccination as preventive approach for recurrent respiratory papillomatosis - a 22-year retrospective clinical analysis.
    Mauz PS; Schäfer FA; Iftner T; Gonser P
    BMC Infect Dis; 2018 Jul; 18(1):343. PubMed ID: 30041619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent respiratory papillomatosis: A state-of-the-art review.
    Fortes HR; von Ranke FM; Escuissato DL; Araujo Neto CA; Zanetti G; Hochhegger B; Souza CA; Marchiori E
    Respir Med; 2017 May; 126():116-121. PubMed ID: 28427542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bevacizumab as adjuvant therapy for recurrent respiratory papillomatosis in an infant.
    Gates C; Tomboc P; Allison A; Carr M
    Int J Pediatr Otorhinolaryngol; 2020 Feb; 129():109762. PubMed ID: 31707187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.